Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/16
End: 11/30/19
Due: 11/30/20
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 12/31/14
Due: 12/31/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab | NCT02992301 | Westside Medical Associates of Los Angeles | user2@example.com | None | 2016-11-30 | 2019-11-30 | 2020-11-30 | - | - | 2025-07-14 |
| Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy | NCT01804543 | Westside Medical Associates of Los Angeles | user2@example.com | None | 2012-06-30 | 2014-12-31 | 2015-12-31 | - | - | 2025-07-14 |